
Medical Oncology Specialist
Dr. Vildan Kayku
Areas of Interest
- Breast cancer
- Lung cancer
- Colorectal cancer
- Prostate cancer
- Skin cancer
- Gastric (stomach) cancer
- Liver cancer
- Cervical (uterine) cancer
- Kidney cancer
- Pancreatic cancer
- Esophageal cancer
Education
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology
2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine
1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine
Eskişehir Osmangazi University Faculty of Medicine
Work Experience
2024
Neolife Medical Center
2024
Kolan Beylikdüzü Hospital
2023 – 2024
Memorial Bahçelievler Hospital
2020 – 2023
Acıbadem Maslak Hospital
2019 – 2020
Istanbul Aydın University VM Medical Park Florya Hospital
2017 – 2019
Republic of Turkey, University of Health Sciences, Van Training and Research Hospital
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology
2013 – 2014
Kars State Hospital
2009 – 2013
Ufuk University Dr. Rıdvan Ege Hospital, Department of Internal Medicine
2007 – 2009
Hacettepe University Faculty of Medicine, Department of Physiology
Professional Trainings
- Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, and National Immunotherapy & Oncology Congresses
- Courses organized by the Turkish Society of Medical Oncology
Memberships
- Turkish Society of Medical Oncology
- Istanbul Medical Chamber
Scientific Contributions
- 6 scientific articles published in national and international journals
- 21 papers presented at national congresses
- 3 papers presented at international congresses
- 1 book chapter translation:
Atlas of Internal Medicine, 3rd Edition – Chapter 12: Hepatology (Turkish Translation) - 3 authored book chapters:
- Immunotherapy in Oncology – Immunotherapy in Small Cell Lung Cancer, Chapter 13, 2020
- Endocrine System Tumors – The Role of Immunotherapy in Neuroendocrine Tumors, Chapter 41, 2021
- Antineoplastic Drugs – Mechanisms of Action and Classification of Antimetabolites, Chapter 14, 2022
- 1 oral presentation at a national congress:
Chemotherapy in Cervical Cancer, 3rd National Urogenital Cancers Congress, 2019




